Congressionally Directed Medical Research Programs -- Prostate Cancer Research Program -- Physician Research Award

Funding Agency:
Department of Defense

The FY20 PCRP Physician Research Award supports a mentored research experience to prepare physicians with clinical duties and/or responsibilities for productive careers in prostate cancer research. The mentored physician is considered the Principal Investigator (PI) of the application. This award emphasizes equally the quality of the proposed research project and the career development of the PI, which should prepare physicians for careers in basic, population science, translational, or clinical prostate cancer research. All applications for the FY20 PCRP Physician Research Award are to be written by the PI, with appropriate direction from the Mentor(s). 
 

Deadlines:
• Required Pre-Application Submission Deadline: June 4, 2020
• Application Submission Deadline:  June 18, 2020

Agency Website

Areas of Interest

The mission of the FY20 PCRP is to fund research that will lead to the elimination of death from prostate cancer and enhance the well-being of Service members, Veterans, and all the men and their families who are experiencing the impact of the disease. Within this context, the PCRP is interested in supporting research that addresses specific gaps in prostate cancer research and clinical care, with an emphasis on investing in research that will benefit patients diagnosed with lethal prostate cancer or improve quality of life for men diagnosed with this disease. Therefore, applications are required to address one or more of the following FY20 PCRP Overarching Challenges:

• Improve the quality of life for survivors of prostate cancer

• Develop treatments that improve outcomes for men with lethal prostate cancer: Applications must be directly relevant to lethal prostate cancer, which includes patients with metastatic disease; treatment-resistant disease; oligo-metastases; neuroendocrine disease; high-risk localized or locoregional disease, etc.

• Reduce lethal prostate cancer in people of African descent, Veterans, and high-risk and underserved populations: High-risk populations include, but are not limited to, people of African descent (including Caribbean Americans), genetically predisposed populations, Service members, and Veterans. Underserved populations include, but are not limited to, men with limited access to clinical care and resources (in both rural and urban settings), and sexual and/or gender minorities with, or at risk for, prostate cancer.

• Define the biology of lethal prostate cancer to reduce death: Applications must be directly relevant to lethal prostate cancer, which includes patients with metastatic disease; treatment-resistant disease; oligo-metastases; neuroendocrine disease; high-risk localized or locoregional disease; etc. Applications should not focus on topics such as differentiation between low risk and intermediate risk prostate cancer.

Eligibility Requirements

The PI must be a physician with clinical duties and/or responsibilities who, at the application submission deadline, is either: ○ In the last year of an accredited graduate medical education program, either as a resident or fellow, or ○ Within 5 years of having initiated his/her first faculty appointment (including Instructor positions)

Amount

$750,000

Amount Description

The anticipated direct costs budgeted for the entire period of performance for an FY20 PCRP Physician Research Award will not exceed $750,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.

Funding Type

Award
Grant

Eligibility

Grad/Prof Students
Junior Faculty
Medical Fellow/Resident

Category

Environmental & Life Sciences
Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

June 4, 2020